Some antibiotics – those administered by injection or infusion – have been covered by the release of compulsory stocks in force since November 1, 2019. The government is now extending this to tablets and capsules that can be taken from the stocks in large quantities.
Compulsory stocksExternal link are aimed at stockpiling essential goods in case of crisis. With regard to medicines, all companies putting a listed vital drug onto the Swiss market for the first time are bound by law to hold compulsory stocks.
Switzerland has experienced problems with antibiotic supplies in the past, but the situation has worsened in the wake of the Covid-19 pandemic and then because of an ongoing wave of infections, FONES explained.
In Switzerland the main suppliers of oral antibiotics are sourced from the same European producer. As the producer is facing capacity problems, it is rationing the antibiotics supplied to different countries.
Popular Stories
More
Workplace Switzerland
Trump tariff shock: how Switzerland is positioning itself
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Men in Switzerland under pressure to uphold social standing
This content was published on
A study from the University of Bern reveals that men in relatively gender-equal countries face significant pressure to maintain their high social status.
Ivory Coast court bars former Credit Suisse CEO from presidential race
This content was published on
The court removed opposition politician and former CEO of Credit Suisse Tidjane Thiam from the electoral roll, citing the loss of his Ivorian nationality.
Novartis and Sanofi call for higher drug prices in Europe
This content was published on
Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.
WHO braces for staff cuts in Geneva amid US funding withdrawal
This content was published on
WHO’s Director-General warned US budget cuts are putting the agency in financial trouble, leading to management cuts in Geneva.
Parmelin meets Swiss businesses in US as IMF predicts 0.9% growth for Switzerland
This content was published on
Economics Minister Guy Parmelin met Swiss businesses in the US during IMF and World Bank meetings. The IMF now forecasts 0.9% GDP growth for Switzerland.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Faced with shortages, Switzerland plans to boost drug stocks
This content was published on
Faced with the current shortage of medicines, Bern wants to extend mandatory reserves of drugs and the obligation to declare stocks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.